Image

Neuropathic Pain and Operant Conditioning of Cutaneous Reflexes After SCI

Neuropathic Pain and Operant Conditioning of Cutaneous Reflexes After SCI

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The purpose of the second part of the study is to examine the effect of reflex training in the leg to decrease neuropathic pain. For this, the researchers are recruiting 15 individuals with neuropathic pain due to spinal cord injury to participate in the reflex training procedure. The study involves approximately 50 visits with a total study duration of about 6.5 months (3 months for baseline and training phases followed by 1 month and 3 month follow-up visits).

Description

As part of the larger study of the relationship between reflexes in the leg and the presence of neuropathic pain, the researchers are also recruiting 30 individuals with spinal cord injury (SCI) total, 15 individuals with neuropathic pain due to SCI and 15 individuals without neuropathic pain. For this portion of the study, there are 2 visits. The first visit will examine cutaneous reflexes in the leg. During the second visit, the study team will assess sensation in the leg and administer questionnaires about pain, functioning, and quality of life. This portion of the study does not involve an intervention.

The study will then recruit 15 individuals who will participate in reflex training, as described in the brief summary.

Eligibility

Inclusion Criteria:

  1. neurologically stable (>1 year post SCI)
  2. medical clearance to participate
  3. ability to stand with or without an assistive device for at least 3 minutes at a time
  4. expectation that current medication will be maintained without change for at least 3 months (stable use of anti-spasticity medication is accepted)
  5. For participants with neuropathic pain, the area of neuropathic pain must include lower leg.

Exclusion Criteria:

  1. motoneuron injury
  2. known cardiac condition
  3. medically unstable condition (incl. pregnancy)
  4. cognitive impairment
  5. uncontrolled peripheral neuropathy
  6. frequent use of electrical spinal stimulation (either transcutaneous or epidural) for pain treatment
  7. daily use of electrical stimulation to the leg
  8. complete lack of cutaneous sensation around foot.

Study details
    Spinal Cord Injuries
    Neuropathic Pain
    Neurological Injury
    Pain

NCT05492188

Medical University of South Carolina

7 May 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.